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Abstract
Purpose: CBCT-based adaptive radiotherapy requires daily images for accurate dose
calculations. This study investigates the feasibility of applying a single convolutional
network to facilitate CBCT-to-CT synthesis for head-and-neck, lung and breast cancer
patients.
Methods: Ninety-nine patients diagnosed with head-and-neck, lung or breast cancer
undergoing radiotherapy with CBCT-based position verification were included in this
study. CBCTs were registered to planning CTs according to clinical procedures. Three
cycle-consistent generative adversarial networks (cycle-GANs) were trained in an un-
paired manner on 15 patients per anatomical site generating synthetic-CTs (sCTs).
Another network was trained with all the anatomical sites together. Performances of
all four networks were compared and evaluated for image similarity against rescan CT
(rCT). Clinical plans were recalculated on CT and sCT and analysed through voxel-
based dose differences and γ-analysis.
Results: A sCT was generated in 10 seconds. Image similarity was comparable be-
tween models trained on different anatomical sites and a single model for all sites. Mean
dose differences < 0.5% were obtained in high-dose regions. Mean gamma (2%,2mm)
pass-rates > 95% were achieved for all sites.
Conclusions: Cycle-GAN reduced CBCT artefacts and increased HU similarity to
CT, enabling sCT-based dose calculations. The speed of the network can facilitate on-
line adaptive radiotherapy using a single network for head-and-neck, lung and breast
cancer patients.
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I. Introduction
In modern external beam image-guided radiotherapy (IGRT), cone-beam computed tomo-
graphy (CBCT) plays a crucial role in accurate patient position verification1,2,3. Also, CBCT
can facilitate adaptive radiotherapy (ART) by visualising daily anatomical variations4,5.
CBCT image quality is inferior to that of CT in soft-tissue contrast and Hounsfield Units
(HU) consistency due to the presence of artefacts6,7,8. Therefore, CBCT is not sufficient
to perform accurate dose calculations9 and patients need to be referred for a rescan CT
(rCT) whenever anatomical differences are noted between daily images and planning CT10.
However, scheduling and acquiring a rCT adds logistic complexity and patient burden to the
treatment. On the contrary, with ART these issues can be addressed by exploiting the daily
CBCT images to reduce set-up errors and eliminate the need for an rCT5. A prerequisite
for online ART is that the CBCT quality and HU accuracy is sufficient to enable dose
calculation.
Considerable literature has recently emerged proposing to correct CBCT imaging arte-
facts and increase image intensity consistency using: look-up table-based approaches11,12,
deformable imaging registration (DIR) of the planning CT to the daily anatomy on
CBCT13,14,15 and model- or Monte Carlo-based methods for scatter estimation and correc-
tion16,17,18. Specifically, DIR enabled accurate dose calculations for head-and-neck (HN)19
but obtained lower dose accuracy in more complex anatomical changes such as lung15 and
pelvis20,21. Also, Monte Carlo-based methods were suitable for ART20,22,23. These tech-
niques can be deployed on a time scale of minutes, which is not acceptable when aiming to
use CBCT images for daily online dose evaluation or online pre-treatment adaptation.
Recently, deep learning has been proposed for fast CBCT artefact correc-
tion24,25,26,27,28,29. Deep learning is a branch of artificial intelligence and machine learning
that involves the use of neural networks to generate a hierarchical representation of the in-
put data to achieve a specific task without the need of hand-engineered features30,31. Deep
learning has shown promising results solving image-to-image translation problems within sec-
onds32,33. In this sense, previous work demonstrated the use of a two-dimensional (2D) U-net
to improve CBCT image quality24,25,26. Moreover, it has been shown that converting CBCT
with deep learning resulted in accurate dose calculation for prostate cancer patients27,29 and
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HN cancer patients28,34.
In this study, we investigate whether CBCTs converted with convolutional networks
may be used as a surrogate of the daily anatomy for dose calculations. We employ a network
trained in an unpaired manner to convert CBCT-to-CT of HN, lung, or breast cancer patients
investigating whether a single network can generalise for the three anatomical sites. A single
network trained for all the anatomical sites was compared to three networks trained per
anatomical site. Performances of all four networks were compared and evaluated for image
similarity and dose calculation accuracy between CT and rCT.
II. Material and methods
II.A. Imaging protocols
Ninety-nine patients diagnosed with HN (33), lung (33) or breast (33) cancer undergoing
radiotherapy were retrospectively included in this study. Irradiations were performed be-
tween May 2016 and February 2019 on Agility linacs (Elekta AB, Sweden) with CBCT-based
pre-treatment position verification.
An rCT was acquired in case anatomical variations were noted on the CBCT. We
included at least fourteen patients with rCT per site.
The (r)CTs were acquired on a Brilliance Big Bore (Philips Healthcare, Ohio, USA);
CBCTs were acquired using X-ray volumetric imaging (XVI, v5.0.2b72 Elekta AB, Sweden)
system. Table 1 reports the imaging protocols for CT, rescan CT (rCT) and CBCT for all the
patients included in the study. CBCTs were acquired with 0.25 rotation/s gantry speed and
5.5 frames/s. All the CBCTs were acquired with a 200◦-arc utilising an empty filter cassette
(F0) in combination with a centred detector panel (S position, maximum FOV=27x27 cm2).
The field-of-view (FOV) was in four cases (elective lymph-nodes irradiations or double-sided
irradiation for breast and HN patients) enlarged to a maximum of 41x41 cm2 using a shifted
detector panel (M position) to accommodate the CTV in the CBCT FOV.
Imaging frequency of CBCT followed the extended non-action limit protocol35: online
corrections (action level 0 mm) were applied in the case of partial or ablative breast irradia-
tion, and offline long (N=3, P=5) and short (N=2, P=3) scheme were applied for irradiations
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Table 1: Overview of CT (including also rescan (r)CT) and CBCT imaging protocols in terms
of field-of-view (FOV), acquisition matrix (Acq matrix), resolution (Res), tube voltage (kVp),
exposure (ms) and current (mA). For exposure and current, the mean value (±σ) was reported
along with the range.
Modality Site
FOVa
Acq matrixa
Resa Voltageb Exposureb Currentb
[cm3] [mm3] [kVp] [ms] [mA]
Head-and-neck
43-70 512 0.83-1.37
120
983±65 159±50
43-70 512 0.83-1.37 923-1090 47-271
30-111 101-535 2-3
(r)CT Breast
47-70 512 0.92-1.37
120
1050±109 63±37
47-70 512 0.92-1.37 923-1332 31-271
31-120 103-400 2-3
Lung
29-70 512 0.57-1.37
120
3886±3095 98±66
29-70 512 0.57-1.37 500-10091 30-271
23-220 76-660 1-3
Head-and-neck
27 135-270 1-2
100c
11±5 14±3
27 135-270 1-2 10-40 10-20
13-53 126-526 1-2
CBCT Breast
27-41 270-540 0.5-1
120
33±2 17±2
27-41 270-540 0.5-1 32-40 16-20
26-53 262-526 0.5-1
Lung
27 270 1-2
120d
31±6 20±1
27 270 1-2 10-40 16-25
26-53 128-528 1-2
aExpressed in RL, AP, FH directions; the range is reported in terms of min-max.
b Reported in terms of mean value and range=min-max.
cExcept for H18 and H20 where kVP was 120.
dExcept for L11, L22 and L24 where kVP was 100.
having > 20 and < 20 fractions, respectively. Imaging frequency may have been increased
after consultation between a medical physicist and a radiotherapist on a single patient-basis
in case large inter-fraction motions were observed in the initial fractions or whenever RT
technicians reported difficulties in reproducing the planning position.
CBCTs were translated to apply clinical set-up corrections and resampled to the plan-
ning CT within the X-ray volumetric imaging (XVI, v5.0.2b72 Elekta AB, Sweden) system.
Registrations were estimated within a clip-box including the CTV based on bone rigid (trans-
lation and rotation) matching36. For the breast patients treated with local RT followed by
a sequential boost, a dual rigid registration was performed based first on bone matching
followed by grey level (soft-tissue) matching37,38. The centre of rotation was assigned as the
centre of the PTV.
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II.B. CBCT-to-CT synthesis
II.B.1. Image pre-processing
Before supplying images to the network, CT and CBCT were cropped to the size of the CBCT
FOV after identifying the so-called “MaskCBCT” according to the following steps. CBCTs were
thresholded at -999.9, obtaining a binary mask. In each transverse slice containing the binary
mask, morphological closure was performed, and the smallest bounding box containing the
mask was found. The biggest circle contained in the bounding box was searched starting
from a radius of 26.9 cm and iteratively increasing its size. The circle was propagated for all
the slices obtaining MaskCBCT. CT and CBCT were cropped in the bounding box containing
MaskCBCT.
In addition to cropping, voxel intensity of CT and CBCT were clipped within the interval
[−1000;3071] HU and image intensity was linearly rescaled to 16-bit.
II.B.2. Network architecture and training
To generate CT from CBCT, a 2D cycle-generative adversarial network (cycle-GAN) was
adopted39. Cycle-GANs enable unpaired training, which, compared to paired training, makes
the network less sensitive to residual mismatch of CT and CBCT40.
The network consisted of two cycles called “forward” and “backwards” during which
GANs generated CT from CBCT and vice-versa. Moreover, so-called “cycle-consistency” was
enforced with an L1-norm such that after converting from CBCT to CT and vice-versa, the
original image should be obtained. The architecture, based on the cycle-GAN provided by
Zhou et al.39, was implemented in Tensorflow (v1.3.0). Nine-blocks residual networks41 were
employed as generators and Patch-GANs42 as discriminators (Figure 1). Stochastic gradient
descendent was used applying an Adam solver43 with learning rate = 0.0002, momentum
parameters β1 = 0.5 and β2 = 0.999. Instance normalisation
44 was employed with a batch
size of 1. The weights of the network were randomly initialised from N (0, 0.02). Weight op-
timisation was performed as in Goodfellow et al.45 alternating between one gradient descen-
dent step on the discriminator network and one step on the generator network after having
performed a forward and backward cycle. A structured loss function GAN+λ · L1+cycle-
consistency with λ = 25 was adopted. The original implementation of the network by Zhou
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Figure 1: Architecture of the nine-block residual network used as a generator (top) and of
the convolutional network called Patch-GAN used as a discriminator. The size of the images
is numerically reported, except for the residual block, where it remains stable. Note that the
nine-blocks are omitted in the schematic. Each of the filters had stride two, kernel size four;
leaky rectilinear rectifier unit had a scalar multiplier of 0.2, padding was applied in reflect
mode.
et al391 was modified to accommodate 16-bit grey-scale images with a size of 256x256.
To train, validate and test the network, patients were split into three datasets: 15
patient per site for training, 8 for validation and the remaining 10 for test. The validation
set was used to aid hyperparameter optimisation and to determine at which iteration the
1https://github.com/xhujoy/CycleGAN-tensorflow
Last edited: December 25, 2019 II.B. CBCT-to-CT synthesis
page 6 Maspero M
training could be stopped to avoid over-fitting (early-stopping), while the test set was used
to evaluate the performance of the network. To investigate the impact on dose calculation
of a different CT, the patients included in the test set were selected among the patients
with an rCT and with CBCT and rCT acquired with minimal time differences. Patients’
demographics were controlled to ensure data balancing in terms of the number of patients in
the three sets. Also, we inspected the ratio of male/female, distribution age, tumour staging
distribution and linac on which CBCT were acquired (Supplementary Material).
Training of the cycle-GAN was performed in the transverse plane, and for each iteration,
random CT, and CBCT slices of different patients were supplied. Three networks were
trained separately on each anatomical site. Another network was trained on all anatomical
sites to investigate whether a single network may generalise for all anatomical sites. The
networks were trained for 200 epochs on a Tesla P100 (16 Gb, NVIDIA, California, USA)
graphical processing unit (GPU) with batch size one and image pool of 1000 images. Data
augmentation was applied during training by flipping the images left and right and randomly
cropping of 30x30 voxels after having bi-linearly resampled the images to 286x286 voxels in
MaskCBCT. Early stopping was applied selecting the earliest epoch for which average L1 in
the body contour over the pts of the validation test was the lowest and within one σ from
L1 calculated at every 10 epoch (a total of 20 models were stored, one each 10 epochs).
The total amount of slices utilised during training was reported to verify data balancing
among sites: 3668 transverse slices acquired in a minimum of four different linacs were
used for training, composed by 1606, 1046 and 1016 slices from HN, lung and breast cancer
patients, respectively.
II.B.3. Image post-processing
First, the trained model was applied within MaskCBCT to the pre-processed CBCTs (as de-
scribed in II.B.1.) obtaining 16-bit images. Then, the HU intensity range of [-1000;3071]
was restored with a linear rescaling obtaining the so-called CBCTconv. CBCTconv were
bi-linearly resampled from a matrix size of 256x256 to the original CBCT resolution.
To generate images for the full CT FOV, the CBCTconv was substituted in the original
CT within the MaskCBCT. The image obtained combining CT and CBCTconv will be referred
to as synthetic-CT (sCT) (Figure 2).
II. MATERIAL AND METHODS II.B. CBCT-to-CT synthesis
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Figure 2: Schematic of the image workflow for a 2D transverse slice of a breast cancer patient.
After image acquisition, registration (1) and pre-processing (2) the trained network is deployed
producing converted CBCT (CBCTconv, 3) which substituted the original CT within MaskCBCT
obtaining the so-called synthetic CT (sCT).
II.C. Evaluation
Image evaluation in terms of similarity between sCT and rCT was performed to assess
whether the single network trained with all the anatomical sites was comparable to the
three networks trained per anatomical site. If performances were comparable, the single
network was considered to assess the appropriateness of the CBCT conversion with the
trained cycle-GAN on the test set with an image and a dose comparison.
II.C.1. Image comparison
Similarities between the image intensity of sCT, CBCT, CT and rCT were calculated within
MaskCBCT in terms of mean absolute error (MAE) and mean error (ME) as proposed by Liang
et al.28. Rescan CT was considered as ground truth, and the metrics were calculated in terms
of mean ±1σ and range. Wilcoxon signed-rank tests were conducted between sCT/rCT and
CT/rCT for MAE. Additional metrics are reported in Supplementary Material.
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II.C.2. Dose comparison
For the patients in the test sets, clinical plans were recalculated on CT, sCT and rCT images
in Monaco (v 5.11.02, Elekta AB, Sweden) using a Monte Carlo algorithm on a grid of 3 mm3
with 5% and 3% statistical uncertainty for volumetric modulated arc therapy (VMAT) and
intensity-modulated radiotherapy (IMRT) plans, respectively. Clinical contours, delineated
by a radiation oncologist on the planning CT, were rigidly transferred to the sCT and rCT
except for the body contour, which was automatically re-delineated. These contours were
considered as volumes of interest (VOIs).
Dose distributions were analysed through relative dose differences (DDsCT =
sCT−rCT
rCT
and DDCT =
CT−rCT
rCT ) in the high dose region (dose > 90% of the prescribed dose). Also,
3D γ-analysis46 with 3%,3mm and 2%,2mm criteria relative to dose on rCT within regions
of 50% prescription dose were performed. For all dose comparisons, a 15 mm cropping in the
proximity of body contour was performed to take account of dose build-up in the proximity
of the skin47.
To investigate the impact of dose difference within VOIs, analysis of dose-volume his-
togram (DVH) points was performed on sCT and rCT. The DVH points analysed were the
maximum dose and mean dose. OARs were considered for such analysis when they were
present in at least four of the patients for each anatomical site: submandibular and parotid
glands, spinal cord, larynx and brain stem for head-and-neck patients; lungs, heart, oesoph-
agus, humerus and spinal cord for breast patients; lungs, heart, oesophagus, spinal cord and
trachea for lung patients.
III. Results
III.A. Network
Cycle-GANs required about eight days and five hours training on a GPU Tesla P100
(NVIDIA Corporation) employing 200 epochs with 3668 slices. As a result of the early
stopping investigation, after inspecting the L1 loss function on the training and validation
set, we opted for utilising 160000 (∼100 epochs), 180000 (∼160 epochs), 180000 (∼170
epochs) iterations for the network trained on HN, breast and lung dataset, respectively, and
III. RESULTS
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360000 iterations (∼100 epochs) for the network trained on all the three sites combined.
Generating sCT required <10 s for an entire CBCT volume (∼70 slices) on GPU and about
40 s on CPU.
III.B. Image comparison
The time between rCT and CBCT in the test set was on average (±σ [min; max]) 1 ± 3
[0;8] days and 29± 11 [8;67] days between CT and CBCT. The increased time between CT
and CBCT may result in larger differences when comparing rCT vs CT compared to sCT
vs rCT. Similarity metrics over the test patients are reported in Table 2.
Table 2: Overview of the image comparison. Image comparison calculated as mean (±1σ)
and range ([min;max]) of the test dataset (30 patients) compared to the reference dataset in
terms of mean absolute error (MAE) and mean error (ME) between the Test image minus the
Ref image.
Site Head-and-Neck Breast Lung
Test Ref
MAE ME MAE ME MAE ME
[HU] [HU] [HU] [HU] [HU] [HU]
CBCT rCT
195±20 -122±33 152±40 71±37 219±44 153±48
[160;230] [-183;-71] [98;213] [7;115] [133;280] [94;230]
sCT single
rCT
53±12 -3±7 66±18 -6±13 83±10 -2±11
networka [37;77] [-15;10] [41;95] [-24;13] [72;104] [-25;10]
sCT separate
rCT
51±12 -6±6 67±18 -5±11 86±9 -5±14
networksb [35;74] [-16;4] [41;98] [-18;14] [73;105] [-28;10]
CT rCT
63±17 -18±15 63±24 8±20 94±23 9±22
[-40;90] [-46;3] [40;115] [-14;54] [68;146] [-33;36]
a sCT obtained from a single network trained on all the anatomical sites.
b sCT obtained from three different networks trained on each anatomical site.
Generic network vs site-specific networks
No statistically significant differences (p>0.35) were found between networks trained per
separate anatomical site and the single network trained with all three anatomical sites. This
justifies the use of the single model trained for all the anatomical sites for assessing the
accuracy of HU and for the dose comparison.
Accuracy of HU
One can notice that similarity increased between sCT and rCT compared to CBCT and rCT;
e.g. MAE decreased from 195±20 (CBCT/rCT) to 53±12 HU (sCT/rCT) for HN. All the
similarity metrics calculated between sCT/rCT and CT/rCT can be considered equivalent
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to the metrics calculated between CT and rCT, with no significant differences (p>0.14) for
all the three anatomical sites. The mean MAE and range for sCT/rCT were smaller than
for CT/rCT due to the reduced time between sCT/rCT, which resulted in less anatomical
differences.
Figure 3, 4, 5 show examples of CBCT and sCT obtained from the single network for a
HN, breast and lung cancer patient, respectively. One can observe that the network reduced
scatter artefacts while retaining anatomical accuracy. Considering an example of lung patient
(Figure 5), one can observe the occurrence of atelectasis between CT and rCT/sCT.
III.C. Dose comparison
Figure 3, 4, 5 report also dose distributions calculated on CT, rCT and sCT along with
their DVHs. One can qualitatively notice small difference between doses on rCT and sCT.
When considering the quantitative results, no significant differences were observed between
DDsCT and DDCT. On average (Table 3), dose differences between sCT/rCT (DDsCT)
were lower then for CT/rCT (DDrCT), e.g. in the high dose region (D> 90%) maximum
mean differences in the range [0.1;0.2]% and [-0.3;0.9]% were found for DDsCT and DDrCT,
respectively.
Table 3: Statistics of the dose comparison of the thirty patients in the test set. The values
are reported as percentage mean±1σ and range [min; max].
sCT vs rCT CT vs rCT
Sites
DD1sCT γ3%,3mm
3 γ2%,2mm
4 DD2rCT γ3%,3mm
3 γ2%,2mm
4
[%] [%] [%] [%] [%] [%]
Head-and-neck
0.1± 0.5 98.4± 1.9 95.3± 2.8 0.9± 1.1 97.0± 2.3 91.1± 4.9
[−0.8; 0.7] [93.4; 100] [90.1; 99.6] [−1.8; 2.0] [92.7; 99.6] [80.7; 97.4]
Breast
0.1± 0.4 96.5± 4.1 89.4± 8.2 −0.3± 0.8 95.7± 5.5 88.8± 9.2
[−0.5; 0.8] [86.1; 99.6] [70.8; 97.8] [−1.7; 0.7] [81.1; 99.5] [66.3; 97.5]
Lung
0.2± 0.9 97.0± 2.9 91.3± 6.2 −0.1± 1.5 95.2± 3.6 87.7± 6.8
[−1.3; 1.8] [91.5; 99.7] [82.3; 98.4] [−2.6; 3.0] [89.8; 99.4] [79.4; 96.6]
cDDsCT =
sCT−rCT
rCT · 100 on dose > 90% of the prescribed dose.
dDDrCT =
rCT−CT
CT · 100 on dose >90% of the prescribed dose.
ePass rates of γ3%,3mm on dose > 50% of the prescribed dose.
fPass rates of γ2%,2mm on dose > 50% of the prescribed dose.
The mean gamma pass rates with the 2%,2mm criteria were higher for sCT/rCT com-
pared to CT/rCT for all VOIs, which is in line with the dose differences observed. All DVH
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points differed on average <0.5% compared to rCT. DVH points differences were < 2% ex-
cept for the heart of a breast patient (B31, -5.6%), the oesophagus of two breast patients
(B30, 3.1% and B31, 2.3%), left lung and spinal cord of two lung patients (L25, -2.1% and
L27, 3.8%, respectively). Images of the patients with doses differences in VOIs > 2% were
inspected on a single-case basis, as reported in the Supplementary Material. We noticed
that large dose differences were in low-dose regions, which are more sensitive to statistical
differences due to the low amount of events in the Monte Carlo dose calculations. For a lung
case (L25), anatomical differences were reported as the cause of the observed differences.
Also, residual artefacts characterised by inhomogeneous HUs seem to be present along the
craniocaudal direction in the lungs for sCT; it appears that for this case the CBCT artefacts
were not fully recovered by the network within the lungs. Also for the other lung case (L27),
anatomical differences were observed in the lung. In addition, we noticed the patient was
obese and the CBCTs were characterised by severe scatter artefacts. On sCT, the spinal
cord was not entirely recovered, possibly resulting in local difference. Besides, the spinal
cord is located in a low-dose region, which may be highlighted when considering metrics as
voxel-wise relative differences.
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H24 sCT20161019, rCT20161020; Presc dose = 70 Gy
CTVp5425
CTVnR5425
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SubmandR
SubmandL
Larynx
Brainstem
body
Figure 3: Sagittal views for the head-and-neck cancer patient H24 of: (1st row) CBCT
(1st column), CT (2nd column), rescan CT (rCT, 3rd column) and synthetic CT (sCT, 4th
column), along with (2nd row) the respective difference to rCT, the doses (3rd row). The
red, black, or green dotted rectangles indicate the position of MaskCBCT. The days refer to
the acquisition date of the rCT. In the 4th row, the DVH is shown for target and OARs of
sCT (continuous lines) and rCT (dashed lines).
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B27 sCT20171024, rCT20171025; Presc dose = 61.18 Gy
CTV4669
CTVb6118
CTVnL14669
LongL
LongR
TotalLung
Esophagus
Heart
SpinalCord
PRVhumerus
body
Figure 4: Coronal views for the breast cancer patient B27 of: (1st row) CBCT (1st column),
CT (2nd column), rescan CT (rCT, 3rd column) and synthetic CT (sCT, 4th column), along
with (2nd row) the respective difference to rCT, the doses (3rd row). The red, black, or green
dotted rectangles indicate the position of MaskCBCT. The days refer to the acquisition date of
the rCT. In the 4th rows, the DVH is shown for target and OARs of sCT (continuous lines)
and rCT (dashed lines).
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L26 sCT20170926, rCT20170926; Presc dose = 30 Gy
ITV3000
Longptv
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Esophagus
Heart
SpinalCord05
Trachea
body
Figure 5: Axial views for the lung cancer patient L26 of: (1st row) CBCT (1st column), CT
(2nd column), rescan CT (rCT, 3rd column) and synthetic CT (sCT, 4th column), along with
(2nd row) the respective difference to rCT, the doses (3rd row). The red, black, or green
dotted rectangles indicate the position of MaskCBCT. The days refer to the acquisition date of
the rCT. In the 4th row, the DVH is shown for target and OARs of sCT (continuous lines)
and rCT (dashed lines).
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IV. Discussion
Cycle-consistent generative adversarial network (cycle-GAN) increased the accuracy of HU
in CBCT, enabling sCT-based calculations for HN, lung and breast cancer patients. Also,
we found that a single network trained on all the three sites performed similarly to three
networks trained on each anatomical site.
When investigating the accuracy of HU on sCT calculating image similarity to rescan
CT, we found that HU values were comparable to values observed between CT and rCT.
We observed a slight increase in performance for HN compared to breast and lung cancer
patients. The network was trained with higher amount of slices for HN (1606) compared to
lung and breast (1046 and 1016, respectively). We hypothesise that this data imbalancing
may have resulted in relatively increased perfomances for HN cancer patients. Also, the
use of immobilisation masks for HN case may increase the reproducibility of patient set-
up or reduce motion artefacts in the images (both CT and CBCT)48. Though variations
in the CBCT imaging protocol were reported, e.g. kV, mAs and linac where the images
were acquired, we did not observe any effect on the quality of sCT. It may be of interest
to investigate thoroughly the influence to the robustness of the method to variations of
acquisition settings, as already proposed by Maier et al.26.
In terms of dose calculation accuracy, we compared sCT to rCT, achieving excellent
results for all the anatomical sites. Previous work with deep learning was performed on
prostate24,27,29,49, HN28,50 and lung25 patients. For HN patients, similar findings were re-
ported by Liang et al.28, where also a cycle-GAN was utilised where a mean (±1σ) 2%, 2mm
γ pass-rates of 98.4±1.7% was obtained compared to 98.4±1.9% of this work. Also, Li et
al. used a 2D U-net with residual convolutional units achieving mean DVH point difference
< 1%50. In our study, similar mean DVH point differences (< 0.5%) were achieved, which
demonstrates the high sCT quality achieved with our approach. For lung patients, Xie et al.
applied patch-based residual learning on lung patients obtaining a conspicuous correction of
cupping and streaking artefacts25. Unfortunately, they did not perform any dose calculations
and used different metrics, making it difficult to compare the studies.
Repositioning inevitably occurred between CBCT, rCT and CT. To further minimise
anatomical and set-up differences, we could have recurred to deformable image registration
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(DIR) to increase the similarity of CBCT/sCT and CT/rCT. However, we opted against
it for the following reasons: (i) since we were trying to reproduce the dose derived by CT-
based calculations, we did not want to modify CT or rCT further; (ii) residual deformation
errors should be thoroughly evaluated51, and this was deemed out of the scope of this
investigation; (iii) recurring to using solely translation mimics the set-up procedure that
is currently performed clinically at the linacs, and we aimed at observing the impact of dose
evaluation in a comparable setting.
The main limitation of this study is deemed to be the cohort size: ten patients per anato-
mical sites in the test set may be considered as a low number. Before clinical implementation,
a study including a larger number of patients should be initiated, paying particular attention
to the data variability and data balancing among anatomical sites. Besides, we did not adapt
the contours of targets and OARs, which is necessary to investigate the clinical impact of
replanning thoroughly. To our knowledge, this is the most extensive study so far presented
utilising a convolutional neural network for sCT generation with ninety-nine included pa-
tients. Also, notwithstanding the relatively limited sample, this work offers valuable insights
into the generalisation capability of a single cycle-GAN, and, in general, in showing that a
single neural network can convert CBCTs of multiple sites.
Currently, we balanced the sites based on the number of patients performing training
with about 1.5 times more images for HN compare to lung and breast patients. It would be
interesting to investigate in a future study whether different balancing may maintain com-
parable image similarity for all the anatomical sites. We believe that further improvements
can be made by balancing data in terms of the number of slices included in the training.
In our study, we showed, for the first time, that a single cycle-GAN can be utilised for
multiple anatomical sites as HN, breast and lung. This finding has important implications
for simplifying the training of a convolutional network since a single network may be adopted
for different anatomical sites. To fully understand whether a single network may facilitate
CBCT-based dose calculations for the whole body, we are currently performing a novel study
including additional anatomical areas, e.g. pelvis, lower abdomen and brain.
The impact of our work is that with a single cycle-GAN CBCTs were converted into
CTs, resulting in sCTs that have sufficient quality to enable dose planning. Also, conversion
occurred in a matter of seconds, which is line with the sCT generation time reported by
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other deep learning approaches for lung25, prostate27,29,49 and HN28,50. We foresee these
as an important step toward online ART. In conventional non-adaptive radiotherapy, this
methodology can be used to evaluate the dosimetric impact of anatomical differences occur-
ring during treatment, supporting the decision to perform a rescan CT or not.
In conclusion, a single cycle-GAN was successfully trained to convert CBCT to CT
using unpaired training data of HN, breast and lung cancer patients. The resulted sCT
resembled a diagnostic quality planning CT and featured the anatomy of the daily CBCT.
In terms of dose calculation accuracy, good results were obtained for all the anatomical sites.
In general, the proposed approach enables considerably fast image conversion, and it may
facilitate online adaptive radiotherapy treatments.
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